Iram, A. et al. 2022. Intralesional Metronidazole (5%) VS Intralesional Meglumine Antimonate in Cutaneous Leishmaniasis. Annals of King Edward Medical University. 28, 2 (Aug. 2022), 180–187. DOI:https://doi.org/10.21649/akemu.v28i2.5107.